The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care

J Palliat Med. 2017 Oct;20(10):1152-1157. doi: 10.1089/jpm.2017.0072. Epub 2017 Jun 9.

Abstract

Background: Red Blood Cell (RBC) transfusions are commonly used in palliative care. RBCs are a finite resource, transfusions carry risks, and the net effect (benefits and harms) is poorly defined for people with life-limiting illnesses.

Objective: To examine the indications and effects of RBC transfusion in palliative care patients.

Design: This international, multisite, prospective consecutive cohort study.

Setting/subjects: Palliative care patients undergoing RBC transfusion.

Measurements: Target symptoms (fatigue, breathlessness, generalized weakness, or dizziness) were assessed before transfusion and at day 7 by treating clinicians, using National Cancer Center Institute Common Terminology Criteria for Adverse Events. Assessment of harms was made at day 2.

Results: One hundred and one transfusions with day 7 follow-up were collected. Median age was 72.0 (interquartile range 61.5-83.0) years, 58% men, and mean Australia-modified Karnofsky Performance Status (AKPS) of 48 (standard deviation [SD] 17). A mean 2.1 (SD 0.6) unit was tranfused. The target symptoms were fatigue (61%), breathlessness (16%), generalized weakness (12%), dizziness (6%), or other (5%). Forty-nine percent of transfusions improved the primary target symptom, and 78% of transfusions improved at least one of the target symptoms. Harms were infrequent and mild. An AKPS of 40%-50% was associated with higher chances of symptomatic benefit in the target symptom; however, no other predictors of response were identified.

Conclusions: In the largest prospective consecutive case series to date, clinicians generally reported benefit, with minimal harms. Ongoing work is required to define the optimal patient- and clinician-reported hematological and functional outcome measures to optimize the use of donor blood and to minimize transfusion-associated risk.

Keywords: anemia; blood transfusion; fatigue; palliative care.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anemia / therapy*
  • Australia
  • Cohort Studies
  • Dyspnea / therapy*
  • Erythrocyte Transfusion / standards*
  • Fatigue / therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Palliative Care / methods*
  • Palliative Care / standards*
  • Prospective Studies
  • Treatment Outcome